1004316-94-2Relevant academic research and scientific papers
INHIBITORS OF CYTOCHROME P450
-
Paragraph 0882, (2015/11/10)
The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
-
Page/Page column 220, (2008/06/13)
The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
